These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4268483)

  • 1. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
    Jessop JD; Johns RG
    Ann Rheum Dis; 1973 May; 32(3):228-32. PubMed ID: 4268483
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
    Lawrence JS
    Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
    Palmer DG; Dunckley JV
    Aust N Z J Med; 1973 Oct; 3(5):461-6. PubMed ID: 4204711
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum gold levels during chrysotherapy with relation to urinary and fecal excretion.
    Harth M
    Clin Pharmacol Ther; 1974 Apr; 15(4):354-60. PubMed ID: 4206926
    [No Abstract]   [Full Text] [Related]  

  • 7. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of two maintenance schedules of chrysotherapy in rheumatoid arthritis: preliminary report.
    Griffin AJ; Gibson T; Taylor A
    Rheumatol Rehabil; 1978; Suppl():99-104. PubMed ID: 103181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 10. Intestinal resorption of gold salts used for treatment of rheumatoid arthritis.
    Sairanen E; Vähätalo S
    Scand J Rheumatol; 1973; 2(2):61-4. PubMed ID: 4201507
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis.
    Lorber A
    Agents Actions Suppl; 1981; 8():539-73. PubMed ID: 6781239
    [No Abstract]   [Full Text] [Related]  

  • 13. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
    Rudge SR; Perrett D; Swannell AJ
    Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sodium aurothiomalate during lactation.
    Bennett PN; Humphries SJ; Osborne JP; Clarke AK; Taylor A
    Br J Clin Pharmacol; 1990 Jun; 29(6):777-9. PubMed ID: 2116162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chrysotherapy and side effects (author's transl)].
    Eberl R
    Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
    Svensson A; Theander J
    Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
    Heath MJ
    Ann Rheum Dis; 1988 Jan; 47(1):18-21. PubMed ID: 3125798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.